Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,095 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma

NCT01965353

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma

NCT01723020

Conditions
Advanced Malignancy, Advanced Solid Tumors, Astrocytoma, +26 more
Locations
  • Research Site Santa Monica, California, United States
  • Research Site Norwalk, Connecticut, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
View all 14 locations
View Trial Details
Completed

Childhood Acute Lymphoblastic Leukaemia: Follow-Up

NCT03545659

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital Aarhus N, Denmark
  • Department of Paediatrics and Adolescent Medicine, Turku University Hospital Turku, Finland
  • The National University Hospital of Iceland Reykjavik, Iceland
  • Department of Childhood Oncology, University Hospital Tromsø Tromsø, Norway
View Trial Details
Completed

Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency

NCT02045017

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +19 more
Locations
  • Krankenhaus der Elisabethinen Linz, I Interne Abteilung Linz, Austria
  • Medizinische Universitat Wien Vienna, Austria
  • Wilhelminenspital der Stadt Wien Vienna, Austria
  • Hopital Dypuytren-CHU de Limoges Limoges, France
View all 22 locations
View Trial Details
Completed

Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)

NCT00161993

Conditions
Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Tampere University Hospital Tampere, Finland
  • Turku University Central Hospital Turku, Finland
  • SU/Sahlgrenska Gothenburg, Sweden
  • University Hospital Lund Lund, Sweden
View Trial Details
Completed

Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT01767766

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
Locations
  • TG Therapeutics Trial Site Sarasota, Florida, United States
  • TG Therapeutics Trial Site Hackensack, New Jersey, United States
  • TG Therapeutics Trial Site New York, United States
  • TG Therapeutics Trial Site Durham, North Carolina, United States
View Trial Details

Related conditions